Difference between revisions of "Ferrario CM, et al, Circulation (2005), cited as Ref 20 in DOI: 10.1007/s11886-020-01293-2 (Q11014)"
Jump to navigation
Jump to search
(Created claim: title (P93): Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2, #quickstatements; #temporary_batch_1592835264664) |
(Created claim: Publication Date (P100): 2005, #quickstatements; #temporary_batch_1592835264664) |
||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2005
| ||||||||||||||
| Property / Publication Date: 2005 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Revision as of 14:15, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Ferrario CM, et al, Circulation (2005), cited as Ref 20 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 (English)
0 references
2005
0 references
